查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
RNA 靶向小分子药物发现市场与 COVID-19 影响分析，按适应症、按药物、按给药途径、最终用户、按国家和地区 - 2023 年的行业分析、市场规模、市场份额和预测 - 2030年
市场调查报告书
商品编码
1339884

RNA 靶向小分子药物发现市场与 COVID-19 影响分析，按适应症、按药物、按给药途径、最终用户、按国家和地区 - 2023 年的行业分析、市场规模、市场份额和预测 - 2030年

RNA Targeting Small Molecule Drug Discovery Market with COVID-19 Impact Analysis, By Indication, By Drug, By Route of Administration, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年 RNA 靶向小分子药物发现市场规模为 12.081 亿美元，2023 年至 2030 年復合年增长率为 21.8%。

RNA 靶向小分子药物发现市场-市场动态：

  • 一些新技术和医疗保健行业提高了市场需求。
  • 为了扩展RNA分子的药物能力，已经开发了各种新技术。因此，许多具有作用于当前和新型 RNA 靶点潜力的小分子也正在临床前和临床研究中进行研究，用于治疗多种适应症，包括传染病、遗传性疾病和其他类型的癌症。因此，这些因素可能会推动对RNA靶向小分子药物发现市场的需求。然而，药物研究的高昂成本是市场增长的主要障碍之一。此外，预计RNA靶向小分子药物发现行业可能会改变医疗保健部门目前治疗各种疾病的方式。与此相一致的是，这些药物通过选择性靶向 RNA 分子发挥作用，RNA 分子对于药物开发来说是有吸引力的目标，因为它们对于控制基因表达很重要。

RNA 靶向小分子药物发现市场 - 主要见解：

  • 根据我们的研究分析师分享的分析，全球 RNA 靶向小分子药物发现市场预计在预测期内（2023-2030 年）每年将以 21.8% 左右的复合年增长率增长
  • 该市场率先开发了选择性靶向 RNA 的药物，为解决医疗需求未得到满足的疾病（例如遗传性疾病和某些癌症）提供了一种有前景的方法。
  • RNA 靶向小分子为药物发现提供了新的维度，补充了传统方法并扩大了可治疗疾病的范围，最终改善了患者的治疗结果。
  • 按地区划分，北美是 2022 年的主要收入来源

RNA 靶向小分子药物发现市场 - 細項分析：

  • 全球RNA靶向小分子药物发现市场根据适应症、药物、给药途径、最终用户和地区进行细分。
  • 根据适应症将市场分为四类：神经系统疾病、癌症、代谢性疾病、传染病等。癌症领域被认为主导市场。由于RNA靶向药物仅针对癌细胞，并且专门针对与癌症相关的基因改变，因此与其他类型的癌症治疗相比，RNA靶向药物在功效和减少副作用方面具有前沿优势。此外，对于癌症治疗，各製药公司正在大力投资 RNA 靶向药物的发现，这可能会推动市场增长。
  • 根据药物，市场分为六类：tomivosertib、translarna、risdiplam、ELX-02、ABX464 和 H3B-6545。 Translarna (TM) 业务预计将占据最大的收入份额。它是为了治疗由称为无义突变的特定类型突变引起的遗传性疾病而创建的。此外，这些突变可能导致多种遗传性疾病，例如某些类型的囊性纤维化和肌营养不良症。此外，在 mRNA 中，Translarna (TM) 促进过早终止密码子的“通读”，使核醣体能够继续翻译并产生全长的功能性蛋白质。这可能会减轻无义突变引起的遗传性疾病的影响。
  • 根据给药途径，市场分为两类：皮下注射和口服。口腔细分市场可能拥有最大的收入份额。由于其患者依从性和便利性，它是药物输送的重要首选途径之一。开发小分子药物口服给药系统的优点是能够通过口服途径轻鬆给药小分子药物，避免侵入性操作，并可能提高患者对治疗方案的依从性。
  • 市场根据最终用户分为两类：学术和研究机构、製药和生物製药公司等。製药和生物製药公司领域可能会在预测期内保持其主导地位。由于他们在药物发现方面拥有丰富的经验和资源，因此该领域预计将继续主导市场。有各种中小型生物製药行业进入市场。

RNA 靶向小分子药物发现市场 - 地理洞察：

从地域上看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

RNA靶向小分子药物发现市场-竞争格局：

在竞争激烈的RNA靶向小分子药物发现行业中，各个行业都在争夺市场主导地位。这些行业凭藉其在 RNA 靶向药物生产和开发方面的资源和经验，在市场上占有重要地位。此外，为了推出新疗法并获得监管许可，他们与监管组织和医疗保健提供者建立了联繫。例如，2023年2月，ReviR Therapeutics与亚虹医药合作开发新的肿瘤疗法。此外，此次合作的目标是开发泌尿生殖肿瘤和其他相关严重疾病的新疗法。

最近的发展：

例如，2023 年 1 月，Atomic AI 发布了价值 3500 万美元的系列产品，用于开发人工智能驱动的 RNA 结构平台，用于治疗不治之症。

该研究的主要特点：

  • 这项针对 RNA 靶向小分子药物发现市场的研究提供了市场规模（百万美元）、年复合成长率（CAGR%）和预测估计（2023-2030 年），以 2022 年为基准年。
  • 该报告为客户提供了有关 RNA 靶向小分子药物发现市场的最新趋势见解。
  • 该研究报告阐明了不同细分市场/国家的潜在增长机会，并解释了针对小分子药物发现市场的 RNA 有吸引力的投资主张矩阵。
  • 总体报告确定了新的投资机会、老牌参与者面临的挑战以及 RNA 靶向小分子药物发现市场维持的增长因素。
  • COVID-19 对 RNA 靶向小分子药物发现市场规模、预测、复合年增长率和市场动态的影响将在研究范围下详细讨论。还将详细介绍新冠疫情后 RNA 靶向小分子药物发现市场。
  • 为了让本报告的用户全面了解RNA靶向小分子药物发现市场，我们还对RNA靶向小分子药物发现市场的竞争格局和关键创新者进行了分析。
  • 该研究包括增长前景映射分析，其中所有行业细分都根据其市场规模、增长率和吸引力进行基准测试。
  • 该报告提供了主要市场参与者的详细公司概况，这些参与者将帮助用户了解在 RNA 靶向小分子药物发现市场中运营的参与者的财务信息和战略倡议。
  • 此外，报告还揭示了全球和区域市场主要参与者的重要收购和兼併、合作和合资、新产品推出、研发、区域扩张。
  • 全球RNA靶向小分子药物发现市场报告主要面向该行业的各个利益相关者，包括供应商、投资者、新进入者、分销商和金融分析师。

目录

第 1 章：RNA 靶向小分子药物发现市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • RNA 靶向小分子药物发现市场片段（按适应症）
    • RNA 靶向小分子药物发现市场片段（按药物）
    • RNA 靶向小分子药物发现市场片段（按给药途径）
    • 最终用户的 RNA 靶向小分子药物发现市场片段
    • RNA 靶向小分子药物发现市场片段（按国家/地区）
    • RNA 靶向小分子药物发现市场片段（按地区）
  • 竞争洞察

第 3 章：RNA 靶向小分子药物发现主要市场趋势

  • RNA 靶向小分子药物发现市场驱动因素
    • 市场驱动因素的影响分析
  • RNA 靶向小分子药物发现市场限制
    • 市场限制影响分析
  • RNA 靶向小分子药物发现市场机会
  • RNA靶向小分子药物发现市场未来趋势

第 4 章：RNA 靶向小分子药物发现行业研究

  • PEST分析
  • 波特五力分析
  • 增长前景图
  • 规范架构分析

第 5 章：RNA 靶向小分子药物发现市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的细分市场
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：RNA 靶向小分子药物发现市场格局

  • 2022 年 RNA 靶向小分子药物发现市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：RNA 靶向小分子药物发现市场 - 按适应症

  • 概述
    • 按指标分類的细分市场份额分析
    • 神经系统疾病
    • 癌症
    • 代谢性疾病
    • 传染病
    • 其他的

第 8 章：RNA 靶向小分子药物发现市场 - 按药物

  • 概述
    • 按药物分類的细分市场份额分析
    • 托米沃塞蒂布
    • 特兰斯拉纳 (TM)
    • 瑞斯迪普兰
    • ELX-02
    • ABX464
    • H3B-6545

第 9 章：RNA 靶向小分子药物发现市场 - 按给药途径

  • 概述
    • 按给药途径分類的细分市场份额分析
    • 皮下
    • 口服

第 10 章：RNA 靶向小分子药物发现市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场份额分析
    • 学术及研究机构
    • 製药和生物製药公司
    • 其他的

第 11 章：RNA 靶向小分子药物发现市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场份额分析
  • 北美
    • 概述
    • RNA 靶向小分子药物发现北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按指标）
    • 北美市场规模和预测（按药物）
    • 北美市场规模和预测（按管理途径）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • RNA 靶向小分子药物发现欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按指标）
    • 欧洲市场规模和预测（按药品）
    • 欧洲市场规模和预测（按管理途径）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 意大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • RNA 靶向小分子药物发现亚太地区主要製造商
    • 亚太地区市场规模和预测（按国家）
    • 亚太地区市场规模和预测（按指标）
    • 亚太地区药物市场规模和预测
    • 亚太地区市场规模和预测（按管理途径）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳大利亚
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉美
    • 概述
    • RNA 靶向小分子药物发现拉丁美洲主要製造商
    • 拉丁美洲市场规模和预测（按国家）
    • 拉丁美洲市场规模和预测（按指标）
    • 拉丁美洲市场规模和预测（按药品）
    • 拉丁美洲市场规模和预测（按管理途径）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • RNA靶向小分子药物发现中东和非洲的主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按指标）
    • 中东和非洲市场规模及预测（按药品）
    • 中东和非洲市场规模及预测（按管理途径）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 火鸡
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - RNA 靶向小分子药物发现行业

  • 竞争仪表板
  • 公司简介
    • PTC Therapeutics
    • Accent Therapeutics
    • Expansion Therapeutics
    • Anima Biotech Inc.
    • Servier Laboratories
    • Arrakis Therapeutics
    • AstraZeneca
    • Skyhawk Therapeutics, Inc.
    • Epics Therapeutics
    • H3 Biomedicine Inc.
    • Hoffmann-La Roche Ltd
    • Ribometrix
    • AC immune
    • STORM Therapeutics

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联繫我们
Product Code: ANV1608

REPORT HIGHLIGHT

RNA targeting small molecule drug discovery Market size was valued at USD 1,208.1 Million in 2022, expanding at a CAGR of 21.8% from 2023 to 2030.

RNA targeting small molecules drug discovery refers to the process of examining and developing small molecule drugs that specifically inhibit and modulate the function of RNA molecules within cells. RNA, or ribonucleic acid, plays an essential role in several cellular processes, including regulation and gene expression. Moreover, a tiny molecule is an organic compound with a relatively low, molecular weight that can interact with biological targets including nucleic acids or proteins.

RNA Targeting Small Molecule Drug Discovery Market- Market Dynamics:

  • Several novel techniques and the healthcare sector raising the market demand.
  • To expand the drug ability of RNA molecules various novel techniques have been developed. As a result, numerous small molecules, with the potential of acting on current and novel RNA targets are also being studied in preclinical and clinical studies for the treatment of several indications, including infectious diseases, genetic diseases, and other types of cancers. Thus, such factors may drive the demand for the RNA targeting small molecules drug discovery market. However, the exorbitant cost of medication research is one of the main obstacles to the market growth. Moreover, it is projected that the RNA targeting small molecules drug discovery industry could transform the way the healthcare sector currently treats various diseases. In line with this, these drugs function by selectively targeting RNA molecules, which are appealing targets for drug development as they are important for controlling gene expression.

RNA Targeting Small Molecule Drug Discovery Market- Key Insights:

  • As per the analysis shared by our research analyst, the global RNA targeting small molecule drug discovery market is estimated to grow annually at a CAGR of around 21.8% over the forecast period (2023-2030)
  • This market pioneers the development of drugs that selectively target RNA, presenting a promising approach to tackle diseases with unmet medical needs, such as genetic disorders and certain cancers.
  • RNA-targeted small molecules offer new dimensions to drug discovery, complementing traditional approaches and broadening the scope of treatable conditions, ultimately improving patient outcomes.
  • On the basis of region, North America was the leading revenue generator in 2022

RNA Targeting Small Molecule Drug Discovery Market- Segmentation Analysis:

  • The global RNA targeting small molecule drug discovery market is segmented on the basis of indication, drug, route of administration, end-user, and region.
  • The market is divided into four categories based on indication: neurological diseases, cancer, metabolic diseases, infectious disease, and others. The cancer segment is accounted to dominate the market. As they target cancer cells only and are created to specifically target cancer-related genetic alterations, RNA-targeted drugs have a cutting-edge as compared to other types of cancer treatments in terms of efficacy and side effects reduction. Moreover, for cancer treatment various pharmaceutical companies are investing heavily in RNA-targeted drug discovery, which is likely to fuel the market growth.
  • The market is categorized into six categories based on the drug: tomivosertib, translarna, risdiplam, ELX-02, ABX464, and H3B-6545. The translarna™ segment is expected to witness the largest revenue share. It is created to treat genetic disorders caused by a particular type of mutation known as a nonsense mutation. Additionally, these mutations can lead to several genetic disorders such as certain types of cystic fibrosis and muscular dystrophy. Moreover, in the mRNA Translarna™ promotes "read-through" of the premature stop codon, allowing the ribosome to continue translating and create a full-length, functional protein. This might mitigate the effects of the genetic disorder caused by the nonsense mutation.
  • The market is segmented into two categories based on the route of administration: subcutaneous and oral. The oral segment is likely to possess the largest revenue share. As it is one of the crucial preferred routes for drug delivery owing to its patient compliance and convenience. The capability to administer small molecule medications easily by oral route, avoidance of invasive procedures, and potentially improved patient adherence to treatment regimens are the advantages of developing oral delivery systems for small molecule medications.
  • The market is divided into two categories based on end-user: academic and research institutes, pharmaceutical and biopharmaceutical companies, and others. The pharmaceutical and biopharmaceutical companies segment is likely to maintain its dominance over the forecast period. As they have huge experience and resources in terms of drug discovery, and as a result, the segment is expected to continue to dominate the market. There are various small to medium-sized biopharmaceutical sectors penetrating the market.

RNA Targeting Small Molecule Drug Discovery Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

RNA Targeting Small Molecule Drug Discovery Market- Competitive Landscape:

In the competitive RNA-targeting small molecule drug discovery industry, various industries are contending for market dominance. These industries have a substantial presence on the market, based on their resources and experience in the production and development of RNA-targeted pharmaceuticals. Moreover, to introduce new treatments and get regulatory permission, they have developed connections with regulatory organizations and healthcare providers. For instance, in February 2023, ReviR Therapeutics collaborated with Asieris to develop new oncology therapies. Additionally, developing new treatments for genitourinary tumors and other related serious diseases is the aim of this collaboration.

Recent Developments:

For instance, in January 2023, Atomic AI released a $35 million series for the advancement of an AI-driven RNA structure platform for the treatment of incurable diseases.

Key features of the study:

  • This proposed research study on RNA targeting small molecule drug discovery market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The report provides the client the latest up-to-date and trending insights about the RNA targeting small molecule drug discovery market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for RNA targeting small molecule drug discovery market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the RNA targeting small molecule drug discovery market.
  • Impact of COVID-19 on RNA targeting small molecule drug discovery market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on RNA targeting small molecule drug discovery market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the RNA targeting small molecule drug discovery market, we have also included competitive landscape and key innovator analysis for the RNA targeting small molecule drug discovery market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the RNA targeting small molecule drug discovery market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global RNA targeting small molecule drug discovery market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET KEY PLAYERS

  • PTC Therapeutics
  • Accent Therapeutics
  • Expansion Therapeutics
  • Anima Biotech Inc.
  • Servier Laboratories
  • Arrakis Therapeutics
  • AstraZeneca
  • Skyhawk Therapeutics, Inc.
  • Epics Therapeutics
  • H3 Biomedicine Inc.
  • Hoffmann-La Roche Ltd
  • Ribometrix
  • AC immune
  • STORM Therapeutics

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY INDICATION

  • Neurological Diseases
  • Cancer
  • Metabolic Diseases
  • Infectious Disease
  • Others

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY DRUG

  • Tomivosertib
  • Translarna
  • Risdiplam
  • ELX-02
  • ABX464
  • H3B-6545

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY ROUTE OF ADMINISTRATION

  • Subcutaneous
  • Oral
  • Others

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY END-USER

  • Academic and Research Institutes
  • Pharmaceutical and Biopharmaceutical Companies
  • Others

GLOBAL RNA TARGETING SMALL MOLECULE DRUG DISCOVERY MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. RNA Targeting Small Molecule Drug Discovery Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. RNA Targeting Small Molecule Drug Discovery Market Snippet by Indication
    • 2.1.2. RNA Targeting Small Molecule Drug Discovery Market Snippet by Drug
    • 2.1.3. RNA Targeting Small Molecule Drug Discovery Market Snippet by Route of Administration
    • 2.1.4. RNA Targeting Small Molecule Drug Discovery Market Snippet by End-user
    • 2.1.5. RNA Targeting Small Molecule Drug Discovery Market Snippet by Country
    • 2.1.6. RNA Targeting Small Molecule Drug Discovery Market Snippet by Region
  • 2.2. Competitive Insights

3. RNA Targeting Small Molecule Drug Discovery Key Market Trends

  • 3.1. RNA Targeting Small Molecule Drug Discovery Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. RNA Targeting Small Molecule Drug Discovery Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. RNA Targeting Small Molecule Drug Discovery Market Opportunities
  • 3.4. RNA Targeting Small Molecule Drug Discovery Market Future Trends

4. RNA Targeting Small Molecule Drug Discovery Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. RNA Targeting Small Molecule Drug Discovery Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. RNA Targeting Small Molecule Drug Discovery Market Landscape

  • 6.1. RNA Targeting Small Molecule Drug Discovery Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. RNA Targeting Small Molecule Drug Discovery Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2022&2030 (%)
    • 7.1.2. Neurological Diseases
    • 7.1.3. Cancer
    • 7.1.4. Metabolic Diseases
    • 7.1.5. Infectious Disease
    • 7.1.6. Others

8. RNA Targeting Small Molecule Drug Discovery Market - By Drug

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drug, 2022&2030 (%)
    • 8.1.2. Tomivosertib
    • 8.1.3. Translarna™
    • 8.1.4. Risdiplam
    • 8.1.5. ELX-02
    • 8.1.6. ABX464
    • 8.1.7. H3B-6545

9. RNA Targeting Small Molecule Drug Discovery Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2022&2030 (%)
    • 9.1.2. Subcutaneous
    • 9.1.3. Oral

10. RNA Targeting Small Molecule Drug Discovery Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-user, 2022&2030 (%)
    • 10.1.2. Academic and Research Institutes
    • 10.1.3. Pharmaceutical and Biopharmaceutical Companies
    • 10.1.4. Others

11. RNA Targeting Small Molecule Drug Discovery Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. RNA Targeting Small Molecule Drug Discovery Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- RNA Targeting Small Molecule Drug Discovery Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. PTC Therapeutics
    • 12.2.2. Accent Therapeutics
    • 12.2.3. Expansion Therapeutics
    • 12.2.4. Anima Biotech Inc.
    • 12.2.5. Servier Laboratories
    • 12.2.6. Arrakis Therapeutics
    • 12.2.7. AstraZeneca
    • 12.2.8. Skyhawk Therapeutics, Inc.
    • 12.2.9. Epics Therapeutics
    • 12.2.10. H3 Biomedicine Inc.
    • 12.2.11. Hoffmann-La Roche Ltd
    • 12.2.12. Ribometrix
    • 12.2.13. AC immune
    • 12.2.14. STORM Therapeutics

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by Indication2018-2030 (USD Million)
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: DrugSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by Drug2018-2030 (USD Million)
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: End-user Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-user
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by End-user 2018-2030 (USD Million)
  • TABLE RNA Targeting Small Molecule Drug Discovery Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global RNA Targeting Small Molecule Drug Discovery Market, by Region 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by Drug, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market, by End-user, 2018-2030 (USD Million)

List of Figures

  • FIGURE RNA Targeting Small Molecule Drug Discovery Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Indication segment market share analysis, 2022&2030
  • FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Drug segment market share analysis, 2022&2030
  • FIGURE Drug segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022&2030
  • FIGURE Route of Administrationsegment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-user segment market share analysis, 2022&2030
  • FIGURE End-user segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE Europe RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE Latin America RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe RNA Targeting Small Molecule Drug Discovery Market share analysis by country, 2022
  • FIGURE Germany RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific RNA Targeting Small Molecule Drug Discovery Market share analysis by country, 2022
  • FIGURE India RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America RNA Targeting Small Molecule Drug Discovery Market share analysis by country, 2022
  • FIGURE Brazil RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market share analysis by country, 2022
  • FIGURE Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA RNA Targeting Small Molecule Drug Discovery Market size, forecast and trend analysis, 2018 to 2030 (USD Million)